All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Ongoing | 2005-001481-14 | LOCAL-TAX Trial: Local intracoronary administration of Paclitaxel after stent implantation for prevention of restenosis in comparison with stent implantation alone and with implantation of a Paclitaxe... | not-yet-due | |
Reported results | 2005-003305-90 | A Randomized Phase II Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD after Unrelated Donor G-CSF mobilized Peripheral Blood Mononuclear Cell (G-PBMC)... | 2014-12-31 | due-trials |
Not reported Terminated | 2005-004540-31 | Monozentrische, randomisierte, placebo-kontrollierte Studie zur Evaluation der Nephroprotektion durch Theophyllin unter Cisplatin-haltiger Chemotherapie | 2009-12-15 | due-trials |
Exempt | 2005-005678-61 | Entwicklung einer Untersuchungsmethode zur Bestimmung des NO-Transferfaktors der Lunge Evaluierung der Methode und Normwerterhebung an gesunden Probanden (Development of a new method for steady-state ... | not-yet-due | |
Not reported | 2006-003816-23 | Multicenter phase II study with pemetrexed in patients with pre-treated metastatic soft tissue sarcomas | 2009-12-15 | due-trials |
Not reported Terminated | 2007-000353-65 | Weight gain, eating patterns, and development of body composition during initiation of basal insulin therapy: a comparison of insulin detemir and insulin glargine | 2012-10-18 | due-trials |
Not reported Terminated | 2007-000775-42 | Effects of Rimonabant on Liver Fat, Visceral Adipose Tissue Mass and early Markers of CardioDiabetes in obese Subjects with the Metabolic Syndrome – a randomized, double-blind clinical trial | 2008-12-15 | due-trials |
Ongoing | 2007-001478-10 | CWS-2007-HR: A randomised phase-III trial of the Cooperative Weichteilsarkom Studiengruppe for localised high-risk Rhabdomyosarcoma and localised Rhabdomyosarcoma-like Soft Tissue Sarcoma in children,... | not-yet-due | |
Ongoing | 2007-003858-29 | Prospektive multizentrische Phase-III-Studie zur ambulanten Therapie mit Capecitabin versus Cisplatin plus Capecitabin beim fortgeschrittenen Adenokarzinom der Gallenblase und Gallenwege („CISCA-Studi... | not-yet-due | |
Not reported | 2007-003986-42 | Prospective, randomised, placebo controlled, double blind monocenter trial for the prophylactic treatment of diarrhoea with rifaximin for travellers to South- and Southeast-Asia | 2012-09-21 | due-trials |
Not reported | 2007-004941-13 | Serumspiegel von intravenös und enteral appliziertem Moxifloxacin bei kritisch kranken Intensivpatienten | 2012-12-31 | due-trials |
Not reported | 2007-005063-96 | Prospective trial of intravenous levetiracetam in patients with primary brain tumors and at least one symptomatic seizure who undergo biopsy or cytoreductive surgery. | 2009-08-19 | due-trials |
Completed, but no date, and reported results Terminated | 2007-006016-33 | Multicenter Phase II study of haploidentical hematopoietic cell transplantation with CD3/CD19 depleted grafts after a reduced intensity conditioning regimen for adult patients with acute leukemia | bad-data | |
Listed as ongoing, but also has a completion date | 2009-012203-26 | Efficacy and safety of inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia. | 2016-07-31 | bad-data |
Completed, report not yet due | 2009-015936-14 | PHASE II FEASIBILITY STUDY USING CH14.18/CHO ANTIBODY AND SUBCUTANEOUS INTERLEUKIN 2 AFTER HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN CHILDREN WITH RELAPSED NEUROBLASTOMA | 2020-06-18 | not-yet-due |
Not reported | 2010-019033-98 | A phase II study to evaluate safety and efficacy of combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma | 2015-06-23 | due-trials |
Ongoing | 2010-021576-28 | Effects of transfusion thresholds on neurocognitive outcome of extremely low birth weight infants (ETTNO) a blinded randomized controlled multicenter trial | not-yet-due | |
Not reported Terminated | 2010-022103-21 | Neoadjuvant treatment of locoregional metastases in malignant melanoma (AJCC stage IIIB/C) with Multiferon: a phase IIa DeCOG trial | 2013-03-31 | due-trials |
Ongoing | 2010-024152-29 | Canakinumab for Behçet`s Disease Resistant to Standard Treatment | not-yet-due | |
Ongoing | 2011-000659-18 | Treatment of therapy resistant Alopecia areata with fumaric acid esters (Fumaderm® and Fumaderm initial®) – an open, single center, non-randomized, pilot study with 40 patients | not-yet-due | |
Reported results | 2011-002192-41 | Multicenter phase II study of peritransplantation immunosuppression using ATG, rituximab, sirolimus and mycophenolate mofetil in patient receiving mismatched hematopoietic cell transplantation after r... | 2016-08-17 | due-trials |
Ongoing | 2011-002434-40 | Highdose Chemotherapy and transplantation of 34+ selected stem cell for progressive systemic sclerosis Modification according to manifestation | not-yet-due | |
Completed, but no date Terminated | 2011-002920-41 | Open-label Trial of Stelara® (Ustekinumab) In Patients with Pyoderma gangrenosum – an open, non-placebo controlled pilot study with 10 patients. | bad-data | |
Not reported Terminated | 2011-004405-25 | Study for prevention of peritoneal carcinomatosis in patients with stomach cancer | 2015-06-09 | due-trials |
Ongoing | 2012-005617-39 | Pharmacokinetics of Tigecycline in Patients Receiving Continuous Renal Replacement Therapy | not-yet-due | |
Completed, report not yet due Terminated | 2013-001546-34 | Neoadjuvant treatment with the combination of vemurafenib and cobimetinib (GDC-0973) in limited metastasis of malignant melanoma (AJCC stage IIIC/IV) and integrated biomarker study: a single armed ph... | 2020-05-14 | not-yet-due |
Not reported | 2013-003306-45 | An open-label, uncontrolled, single arm phase II trial of BKM120 (Buparlisib) in patients with metastatic melanoma with brain metastases not eligible for surgery or radiosurgery | 2018-07-31 | due-trials |
Reported results | 2013-003678-29 | Phase II multicenter, open‐label, single arm clinical Study of Pomalidomide and dexamethasonE in RelapSed myeloma Plus rEsponse adapted Cyclophosphamide as a Tailored InnoVativE strategy | 2017-08-01 | due-trials |
Exempt | 2014-001874-32 | Safety and efficacy of a bilateral single subretinal injection of rAAV.hCNGA3 in adult and minor patients with CNGA3-linked achromatopsia investigated in a randomized, wait list controlled, observer-m... | not-yet-due | |
Exempt | 2014-003561-15 | Safety and Tolerance of Immunomodulating Therapy with Donor-specific Mesenchymal Stem Cells in Pediatric Living-Donor Liver Transplantation | not-yet-due | |
Not reported Terminated | 2014-003581-25 | Anti-inflammatory pulmonal therapy of CF-patients with Amitriptyline and Placebo - Randomised, double-blind, placebo-controlled cohort trial | 2019-09-30 | due-trials |
Ongoing | 2014-005004-21 | THOR - Tübingen Choroideremia gene therapy trial open label Phase 2 clinical trial using an adeno-associated viral vector (AAV2) encoding Rab-escort protein 1 (REP1) | not-yet-due | |
Completed, but no date | 2015-000125-36 | Daptomycin concentration in drainage fluid and blood samples of ICU patients | bad-data | |
Not reported | 2015-000978-35 | Statin Treatment of Oxysterol Pathology in SPG5: a Randomized Controlled Trial -Proof of Principle | 2016-03-01 | due-trials |
Ongoing | 2015-002288-41 | Open-label pilot Phase I / II study on hyperthermic intraperitoneal chemotherapy ( HIPEC ) after macroscopically complete resection ( R0 / R1 ) of adenocarcinomas of the pancreas ( PanHIPEC ) | not-yet-due | |
Completed, but no date Terminated | 2015-003171-29 | The correlation between vancomycin AUC and trough levels during intermittent dosing of vancomycin and plateau levels during continuous infusion - Pharmacokinetic evaluation of Vancomycin and the influ... | bad-data | |
Ongoing | 2015-005281-29 | Prospective phase I/II study: Patient-individualized peptide vaccination based on whole exome sequencing with adjuvant GM-CSF in children with relapsed acute lymphoblastic leukemia | not-yet-due | |
Completed, but no date | 2015-005740-34 | Effectiveness of Dapagliflozin + Saxagliptin to revert from a standard basalbolus insulin treatment (BBIT) regimen to a basal supported oral therapy (BOT) in patients with Type 2 Diabetes – a randomis... | bad-data | |
Ongoing | 2015-005817-61 | iVAC-CLL01: Patient-individualized peptide vaccination after first line therapy of CLL | not-yet-due | |
Other | 2016-000222-19 | Effect of ALlopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome – a blinded randomized placebo-controlled parallel group multicenter trial for superiority ... | not-yet-due | |
Ongoing | 2016-003223-30 | Prophylactic treatment of hemiplegic migraine with Lamotrigine | not-yet-due | |
Ongoing | 2016-003477-18 | A double-blind randomized study to determine the effect of empagliflozin versus placebo on brain insulin sensitivity in patients with prediabetes | not-yet-due | |
Exempt | 2016-003705-34 | PIGMENT – PDE6A gene therapy for retinitis pigmentosa | not-yet-due | |
Ongoing | 2016-004505-13 | Tocilizumab for the Treatment of Familial Mediterranean Fever – A randomized, doubleblind, phase II proof of concept study-TOFFIFE | not-yet-due | |
Completed, but no date Terminated | 2016-004614-10 | An open label phase II study to evaluate safety and efficacy of combined treatment with ipilimumab and nivolumab in patients with four and more symptomatic brain metastases of melanoma | bad-data | |
Ongoing | 2017-001355-31 | Penumbral Rescue by Normobaric O=O Administration in Patients with Ischemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial | not-yet-due | |
Ongoing | 2017-002588-17 | Safety and effects on visual function of 0.01% Atropin eye drops for myopia inhibition in children and adolescents | not-yet-due | |
Not reported | 2017-002723-16 | Evaluation of the potential anti-malarial effect of ivermectin: a controlled human malaria infection trial | 2018-12-12 | due-trials |
Ongoing | 2017-003057-42 | Organ preservation in locally advanced rectal cancer by radiochemotherapy followed by consolidation chemotherapy. A prospective phase II pilot trial of the German Rectal Cancer Study Group | not-yet-due | |
Exempt | 2017-003387-12 | Dopamine action on metabolism depending on genetic heterogeneity – a randomized, placebo-controlled double blind study | not-yet-due | |
Ongoing | 2018-000453-41 | Effects of closed-loop automatic control of the inspiratory fraction of oxygen (FiO2-C) on outcome of extremely preterm infants – a randomized controlled parallel group multicenter trial for safety an... | not-yet-due | |
Other | 2018-001433-41 | Phase II Studie zur Verminderung der Peritonealkarzinose-Inzidenz nach kurativer Gastrektomie eines Magenkarzinoms oder Adenokarzinoms des gastroösophagealen Übergangs durch hypertherme intraperitonea... | not-yet-due | |
Completed, but no date | 2018-003557-21 | Effect of insulin glargine and lixisenatide versus insulin glargine on brain insulin sensitivity in patients with type 2 diabetes | bad-data | |
Exempt | 2018-004523-36 | Safety and protective efficacy of a simplified Plasmodium falciparum sporozoite Chemoprophylaxis Vaccine (PfSPZ-CVac) regimen in healthy malaria-naïve adults in Germany | not-yet-due | |
Ongoing | 2019-002607-18 | Randomized, controlled interventional trial to investigate the efficacy of amiloride for the treatment of edema in human nephrotic syndrome | not-yet-due | |
Ongoing | 2019-004946-13 | Conversion to extended-release MeltDose® tacrolimus after kidney transplantation - impact on glucose metabolism and lipid profile | not-yet-due | |
Other | 2020-001224-33 | Randomized controlled trial of hydroxychloroquine versus placebo for the treatment of adult patients with acute coronavirus disease 2019 – COVID-19 | not-yet-due | |
Completed, report not yet due Terminated | 2020-001482-37 | Randomized controlled trial of hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of elderly COVID-19 Patients | 2021-01-07 | not-yet-due |
Completed, report not yet due Terminated | 2020-001512-26 | Hydroxychloroquine for the treatment of mild COVID-19 disease | 2020-10-12 | not-yet-due |
Ongoing | 2020-002502-75 | P-pVAC-SARS-CoV-2: Phase I single-center safety and immungenicity trial of multi-peptide vaccination to prevent COVID-19 infection in adults | not-yet-due |